Cargando…
Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy
BACKGROUND: Multi-drug Resistance associated Protein-1 (MRP1) can export chemotherapeutics from cancer cells and is implicated in chemoresistance, particularly as is it known to be up-regulated by chemotherapeutics. Our aims in this study were to determine whether activation of Notch signalling is r...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567818/ https://www.ncbi.nlm.nih.gov/pubmed/26362310 http://dx.doi.org/10.1186/s12885-015-1625-y |
_version_ | 1782389849641189376 |
---|---|
author | Kim, Baek Stephen, Sam L. Hanby, Andrew M. Horgan, Kieran Perry, Sarah L. Richardson, Julie Roundhill, Elizabeth A. Valleley, Elizabeth M. A. Verghese, Eldo T. Williams, Bethany J. Thorne, James L. Hughes, Thomas A. |
author_facet | Kim, Baek Stephen, Sam L. Hanby, Andrew M. Horgan, Kieran Perry, Sarah L. Richardson, Julie Roundhill, Elizabeth A. Valleley, Elizabeth M. A. Verghese, Eldo T. Williams, Bethany J. Thorne, James L. Hughes, Thomas A. |
author_sort | Kim, Baek |
collection | PubMed |
description | BACKGROUND: Multi-drug Resistance associated Protein-1 (MRP1) can export chemotherapeutics from cancer cells and is implicated in chemoresistance, particularly as is it known to be up-regulated by chemotherapeutics. Our aims in this study were to determine whether activation of Notch signalling is responsible for chemotherapy-induced MRP1 expression Notch in breast cancers, and whether this pathway can be manipulated with an inhibitor of Notch activity. METHODS: MRP1 and Notch1 were investigated in 29 patients treated with neoadjuvant chemotherapy (NAC) for breast cancer, using immunohistochemistry on matched biopsy (pre-NAC) and surgical samples (post-NAC). Breast epithelial cell cultures (T47D, HB2) were treated with doxorubicin in the presence and absence of functional Notch1, and qPCR, siRNA, Western blots, ELISAs and flow-cytometry were used to establish interactions. RESULTS: In clinical samples, Notch1 was activated by neoadjuvant chemotherapy (Wilcoxon signed-rank p < 0.0001) and this correlated with induction of MRP1 expression (rho = 0.6 p = 0.0008). In breast cell lines, doxorubicin induced MRP1 expression and function (non-linear regression p < 0.004). In the breast cancer line T47D, doxorubicin activated Notch1 and, critically, inhibition of Notch1 activation with the γ-secretase inhibitor DAPT abolished the doxorubicin-induced increase in MRP1 expression and function (t-test p < 0.05), resulting in enhanced cellular retention of doxorubicin and increased doxorubicin-induced apoptosis (t-test p = 0.0002). In HB2 cells, an immortal but non-cancer derived breast cell line, Notch1-independent MRP1 induction was noted and DAPT did not enhance doxorubicin-induced apoptosis. CONCLUSIONS: Notch inhibitors may have potential in sensitizing breast cancer cells to chemotherapeutics and therefore in tackling chemoresistance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1625-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4567818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45678182015-09-13 Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy Kim, Baek Stephen, Sam L. Hanby, Andrew M. Horgan, Kieran Perry, Sarah L. Richardson, Julie Roundhill, Elizabeth A. Valleley, Elizabeth M. A. Verghese, Eldo T. Williams, Bethany J. Thorne, James L. Hughes, Thomas A. BMC Cancer Research Article BACKGROUND: Multi-drug Resistance associated Protein-1 (MRP1) can export chemotherapeutics from cancer cells and is implicated in chemoresistance, particularly as is it known to be up-regulated by chemotherapeutics. Our aims in this study were to determine whether activation of Notch signalling is responsible for chemotherapy-induced MRP1 expression Notch in breast cancers, and whether this pathway can be manipulated with an inhibitor of Notch activity. METHODS: MRP1 and Notch1 were investigated in 29 patients treated with neoadjuvant chemotherapy (NAC) for breast cancer, using immunohistochemistry on matched biopsy (pre-NAC) and surgical samples (post-NAC). Breast epithelial cell cultures (T47D, HB2) were treated with doxorubicin in the presence and absence of functional Notch1, and qPCR, siRNA, Western blots, ELISAs and flow-cytometry were used to establish interactions. RESULTS: In clinical samples, Notch1 was activated by neoadjuvant chemotherapy (Wilcoxon signed-rank p < 0.0001) and this correlated with induction of MRP1 expression (rho = 0.6 p = 0.0008). In breast cell lines, doxorubicin induced MRP1 expression and function (non-linear regression p < 0.004). In the breast cancer line T47D, doxorubicin activated Notch1 and, critically, inhibition of Notch1 activation with the γ-secretase inhibitor DAPT abolished the doxorubicin-induced increase in MRP1 expression and function (t-test p < 0.05), resulting in enhanced cellular retention of doxorubicin and increased doxorubicin-induced apoptosis (t-test p = 0.0002). In HB2 cells, an immortal but non-cancer derived breast cell line, Notch1-independent MRP1 induction was noted and DAPT did not enhance doxorubicin-induced apoptosis. CONCLUSIONS: Notch inhibitors may have potential in sensitizing breast cancer cells to chemotherapeutics and therefore in tackling chemoresistance. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1625-y) contains supplementary material, which is available to authorized users. BioMed Central 2015-09-11 /pmc/articles/PMC4567818/ /pubmed/26362310 http://dx.doi.org/10.1186/s12885-015-1625-y Text en © Kim et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Kim, Baek Stephen, Sam L. Hanby, Andrew M. Horgan, Kieran Perry, Sarah L. Richardson, Julie Roundhill, Elizabeth A. Valleley, Elizabeth M. A. Verghese, Eldo T. Williams, Bethany J. Thorne, James L. Hughes, Thomas A. Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
title | Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
title_full | Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
title_fullStr | Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
title_full_unstemmed | Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
title_short | Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
title_sort | chemotherapy induces notch1-dependent mrp1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567818/ https://www.ncbi.nlm.nih.gov/pubmed/26362310 http://dx.doi.org/10.1186/s12885-015-1625-y |
work_keys_str_mv | AT kimbaek chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT stephensaml chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT hanbyandrewm chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT horgankieran chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT perrysarahl chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT richardsonjulie chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT roundhillelizabetha chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT valleleyelizabethma chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT vergheseeldot chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT williamsbethanyj chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT thornejamesl chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy AT hughesthomasa chemotherapyinducesnotch1dependentmrp1upregulationinhibitionofwhichsensitizesbreastcancercellstochemotherapy |